Research ArticleNuclear Oncology
Glucose Metabolism in Human Malignant Gliomas Measured Quantitatively with PET, l-[C-ll]Glucose and FDG: Analysis of the FDG Lumped Constant
Alexander M. Spence, Mark Muzi, Michael M. Graham, Finbarr O'Sullivan, Kenneth A. Krohn, Jeanne M. Link, Thomas K. Lewellen, Barbara Lewellen, Scott D. Freeman, Mitchel S. Berger and George A. Ojemann
Journal of Nuclear Medicine March 1998, 39 (3) 440-448;
Alexander M. Spence
Mark Muzi
Michael M. Graham
Finbarr O'Sullivan
Kenneth A. Krohn
Jeanne M. Link
Thomas K. Lewellen
Barbara Lewellen
Scott D. Freeman
Mitchel S. Berger
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Glucose Metabolism in Human Malignant Gliomas Measured Quantitatively with PET, l-[C-ll]Glucose and FDG: Analysis of the FDG Lumped Constant
Alexander M. Spence, Mark Muzi, Michael M. Graham, Finbarr O'Sullivan, Kenneth A. Krohn, Jeanne M. Link, Thomas K. Lewellen, Barbara Lewellen, Scott D. Freeman, Mitchel S. Berger, George A. Ojemann
Journal of Nuclear Medicine Mar 1998, 39 (3) 440-448;
Glucose Metabolism in Human Malignant Gliomas Measured Quantitatively with PET, l-[C-ll]Glucose and FDG: Analysis of the FDG Lumped Constant
Alexander M. Spence, Mark Muzi, Michael M. Graham, Finbarr O'Sullivan, Kenneth A. Krohn, Jeanne M. Link, Thomas K. Lewellen, Barbara Lewellen, Scott D. Freeman, Mitchel S. Berger, George A. Ojemann
Journal of Nuclear Medicine Mar 1998, 39 (3) 440-448;
Jump to section
Related Articles
- No related articles found.
Cited By...
- SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
- Mapping 18F-FDG Kinetics Together with Patient-Specific Bootstrap Assessment of Uncertainties: An Illustration with Data from a PET/CT Scanner with a Long Axial Field of View
- Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions
- Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
- Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization?
- Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
- Multiagent PET for Risk Characterization in Sarcoma
- The XbaI G>T Polymorphism of the Glucose Transporter 1 Gene Modulates 18F-FDG Uptake and Tumor Aggressiveness in Breast Cancer
- Transient Focal Increase in Perihematomal Glucose Metabolism After Acute Human Intracerebral Hemorrhage
- Glioma Proliferation as Assessed by 3'-Fluoro-3'-Deoxy-L-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade Glioma
- Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
- Selective defect of in vivo glycolysis in early Huntington's disease striatum
- What Is in a Number? The FDG Lumped Constant in the Rat Brain
- Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
- Kinetic Modeling of 3'-Deoxy-3'-Fluorothymidine in Somatic Tumors: Mathematical Studies
- Kinetic Analysis of 3'-Deoxy-3'-Fluorothymidine PET Studies: Validation Studies in Patients with Lung Cancer
- 18F-FDG Kinetics in Locally Advanced Breast Cancer: Correlation with Tumor Blood Flow and Changes in Response to Neoadjuvant Chemotherapy
- Correlation of Molecular Genetics with Molecular and Morphological Imaging in Gliomas with an Oligodendroglial Component
- The FDG Lumped Constant in Normal Human Brain
- 2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome